Introduction
The rapid and irrepressible increase in antimicrobial resistance more so the ESBLs production by Enterobacteriaceae was a worrying global health concern, posing unique challenges to clinical microbiologists, clinicians, infection control professionals and antibacterial-discovery scientists.β-Lactams are safest and most frequently prescribed antimicrobial agents all over the world in treating Gram positive and Gram negative infections 1 . Betalactamases were numerous and the genes encoding them mutate continuously in response to heavy pressure of antibiotic use.They have spread threateningly in many regions of the world creating serious problem to the currently available antibiotic armory.Being Plasmid mediated, it facilitated the dissemination of resistance not only to β lactams but also to other commonly used antibiotics such as fluoroquinolones and aminoglycosides. 2 Quinolone antibiotics were potent promoters of ESBL transmission.Prevalence of ESBLsin United Statesamong E. coli ranges from 0 to 25% (NNIS) 3 .In Japan <0.1% 4 , in Korea 4.8%, ,in Taiwan8.5%and up to 12% in Hong Kong. 5 In India various authors reported the prevalence of ESBLs ranging from4% to 83%. 6 The first beta-lactamase TEM a plasmid-mediated enzyme named after the patient Temnonierafrom whom it was discovered in Athens of Greece in 1960s,now 175 different TEM enzymes and 127 SHV(Sulfhydryl variable) enzymes exist (www.lahey.org/studies/). Up to 20% of the ampicillin resistance in K pneumoniawas due to SHV-1. In 1989Bauernfeindet al 7 from Germany reported CTX-M-1(Cefotaximase). It had spread globally,currently more than 80 CTX-M enzymes were known.The initial CTX-M arose in the nosocomial setting and spread to the community.The reporting of ESBL producers help the clinicians to select the appropriate antibiotics for the treatment and to take proper precautions to prevent the spread. Some ESBLs may not reach a level to be detected by disk diffusion, but result in treatment failure,identifying the exact ESBL subtype was possible only by molecular detection methods. Though so many types of ESBLs exist majority of the ESBLs were derivatives of TEM, SHV or CTX-M enzymes. Judicious usage of extended-spectrum cephalosporins, periodic surveillance of antibiotic resistance patterns for formulating Antibiotic Policy, and efforts to decrease empirical antibiotic therapy prevent spread and outbreaks of ESBL producing bacteria Co-resistance to fluoro-quinolones, aminoglycosides, trimethoprim-sulphamethoxazole, and beta lactamase inhibitor combinations and susceptibility to carbapanems were determined by disc diffusion method, control strains used were Positive control : ESBL-producing organism (KlebsiellapneumoniaeATCC 700603) Negative control: Non-ESBL-producing organism (Escherichia coli ATCC 25922)
The 86 ESBL producers confirmed by PCT were subjected for detection of genes encoding Beta Lactamases by multiplex PCR amplification using primer sets for blaCTX-M, blaTEM, blaSHV genes, according to the methodology described in the Sambrook and Russell DNA amplification in thermal cycler: An initial denaturation step at 95°C for 5min followed by 35 cycles of denaturation at 95ºc for 30 sec, annealing at 60ºc for 30sec, extension at 72ºc for 2 min ending with a final extension step at 72°C for 10 min and followed by a hold at 4°C.
Agarose gel electrophoresis:Was done for The PCR products with 1.8% agarose gel using suitable molecular weight markers.
DDST PCT1)Gel documentation2)Gel documentation

1)Gel documentation of Multiplex PCR analysis showing 2)Gel documentation of Multiplex PCR
Lane-1 ,50bp DNA ladder,Lane 2 Negative controlanalysisthe presence of ESBL genes. 
Phenotypic And Molecular Characterization Of Esblsproducing Enterobacteriaceaein
IV. Results
Out of 240 Gram Negative isolates, 35.83% were ESBLs producers by PCT and by Vitek 2 system, molecular characterization was found among 32.5%. More number of Isolates were42.1% among 41-60 years of age group, followed by >60yrs (36.5%), 21-40( 26.9%) and 1-20( 18.18%). Males were 38.83%, Females 33.5% (Table1).More number of isolates were fromOP49/86(56.98%) whereas IP 37/86 (43.02%)(Table2).p value 0.0327 statistically significant. Medical and Surgical ICUs yielded 50% followed by ICCU 47%, Ortho 45%, OBG 25%, Surgery 20%, Medicine 16.66% and least from ENT 6.6% (Table 3 ).Higher frequency among Pus samples 41.8% followed by Urine 36.25%, Sputum 33.3% lowest from blood 15%( Table 4 ).Escherichia coliwas the most common isolate 61.63% followed by klebsiella pneumonia30.23%, Proteus species 5.81%, Citrobacter 2.33%. All the isolates were Resistant (100%)toCeftazidime MIC >=4, Cefotaxime, Ceftrioxone MIC>=8, Cefuroxime MIC>=64 andAztreonum MIC>=2, Sensitive (100%) to Imipenem, Meropenem, Doripenem and Ertapenem MIC rangewas<=0.12 to <0.5.
Among theE.coli isolates highest resistance was observed with Nalidixic acid92.45%,followedby Amoxicillin/clavulanicacid 88.67%, Trimethoprim/Sulfmethaxazole84.9%, Ciprofloxacin 81.13%, Levofloxacin 69.81%,Minocycline 67.92% and sensitivity was high with Cefperazone/sulbactam96.23% followed by Piperacillin/Tazobactam79.24%.Most prevalent gene was CTX-M 60.37% followed by TEM11.32%,SHV3.77%,CTX-M+TEM9.4%,CTX-M+ SHV11.32%, not characterized were 3.77 %. Among the Klebsiella isolates resistance was highest 92.3%, with Amoxicillin/clavulanic acid and Ciprofloxacin followed byNalidixic acid 88.46%, Trimethoprim /sulfmethaxazole76.92%, Levofloxacin76.9% and highest sensitivity was observed with Cefperazone/sulbactam 96.16% followed by Gentamycin 69.24%Piperacillin/ Tazobactam 65.39%,Amikacin61.54% (Table 5 ).Out of 86 phenotypically confirmed ESBLs 78 were genotypicallyconfirmed (Table 6) .
Single gene was found in 73.08%, multiple genes were found in 26.92% (Table 7) . Most prevalent gene was CTX-M 34.61%, followed by TEM 15.38%, SHV11.53%, multiple genes were TEM+ SHV 19.23% ,CTX-M+SHV15.38%, not characterized was 3.84%. Proteus species(20%), and Citrobacter(8%) were isolated from surgery department.Among the Proteus SHV(20%) and TEM+SHV(20%), 60% were not characterized, Citrobacter isolates 100% were not characterized (Table 8) ..
V. Discussion
The emergence of ESBL-producing bacteria had been strikingly increasing worldwide, and still considered as threat since they were transferred by plasmid which can be easily transmitted between the species. 13 The therapeutic options for these infections became increasingly narrowed down of the pipeline increasing morbidity and mortality.Hence continuous monitoring systems and effective infection control measures were absolutely necessary.
The 16 .6%fromNepal. Of the 240 isolates ESBL producers by using the PCT were 86(100%), DDST 45.34%. Emery 39 also found DDST could not detect all ESBL-producing isolates. PCT was technically simple cost effective, and 100% in concordance with MIC of Vitek 2 System report.BradfordPA 1 explained that false-positives may occur if the isolate lacks ESBL but produces an excess of TEM-1 or SHV-1on the other hand, isolates harboring both ESBLs and AmpC-type β-lactamases may result in false-negative results.
VITEK 2 system a reliable timesaving tool for routine identification of ESBL-producing strains.All the isolates 86were sensitive100% to Carbapenamsasthese antibiotics were highly stable to β-lactamase activity they remain the only choice of treatment for infections by ESBLs producers.All the Isolates were 100% resistant to 3 rd generation Cephalosporins&Aztreonum, which was in accordance with ManoharanAet al 40 , from Vellore,Sanjeev Kumar et al 41 from Udaipur, Akbar M. Rafay et a 42 from Oman. R.Bonnetet al 43 Nema Shashwati 16 found Most of them were ceftazidimases, and only a few are cefotaximases.This high degree of drug resistance could be due to the availability of drugs to patients with or without any prescription and discontinuing them in the middle of the course.
E.coli isolates showed highest resistance toNalidixic acid 92.45%, followed by Amoxicillin/clavulanicacid 88.67% Trimethoprim/sulfmethaxazole84.9%, Ciprofloxacin 81.13%,Levofloxacin69.81%,Minocycline 67.92%, Nitrofurantoin 60% and sensitivity was 100% for Carbapenam,96.23% for Cefperazone/sulbactam followed by Piperacillin/Tazobactam83.02% which was nearer to the reports of MeetaSarma et al from Jaipur, 12 Wong-Beringer 44 et al.from Pakistan.The Klebsiella isolates were highly resistant to Amoxicillin&clavulanicacid and Ciprofloxacin92.3% followed byNalidixic acid 88.46% Trimethoprim&sulfmethaxozole, Levofloxacin 76.92%, sensitive was 100%for Carbapenam96.16% for Cefperazone/sulbactamfollowed byGentamycin 69.24%, Piperacillin/ Tazobactam 65.39%, Amikacin 61.54%.. Which was near toMeetha Sharma 12 from Jaipur, Ullah et al 45 from Pakistan Jacoby 46 explained, that this may be due to the occurrence of genes encoding resistance to aminoglycoside, trimethoprim-Sulfomethoxazole, and quinolones on the same plasmid that encodes for ESBL production. Martínez-Martínez 47 and colleagues in their analysis found porin loss among the ESBL producing K.pneumoniae also showed active efflux of quinolones, Energy dependent accumulation of Norfloxacin. Out of 86 phenotypically confirmed ESBLs 78 showed genotypic characterization. More number of isolates expressed single genes 73.71% multiple genes were 26.29%. This was nearly correlating withMeeta Sharma 12 from Jaipur, Mehdi Kargar 35 from Iran. Whereas Kaftandzievaet al 48 from Skopze reported mixed genes. Among the ESBLs Producing E.coliCTX-M-60.37% TEM-11.32% SHV-3.77% CTX-M+TEM 9.4%, CTX-M+SHV 11.32%, isolatesnot characterizedwere3.77% nearly correlating withManinderKaur 27 CTX-M genes 59.32%, CTX-M+TEM 8.4%. Meeta Sharma et al 12 from Jaipur CTX-M80%,Ho.P.L 49 observed UTI due to CTX-M ESBL produce E. coli strains, A Manoharanet al 40 observed TEM and CTX-M were predominant. Most prevalent gene among Klebsiella was CTX-M 34.61%, followed by TEM+ SHV 19.23%, TEM 15.38, CTX-M + SHV15.38%, SHV11.53%, not characterizedwas3.84%. Slightly lesser thanFeizabadi MMet al 50 reported bla(CTX-M-I) 46 
VI. Conclusion
ESBL strains are usually multi-drug resistant. Quick detection of these strains in microbiology laboratories is very important,A combination of different tests can be useful for accurate identification so that appropriate treatment is instituted to reduce morbidity and mortality substantially. Data on institutional antibiograms are necessary for formulating antibiotic policy and for Antibiotic Stewardship to control Hospital Acquired Infections(HAI). An appropriate and judicious antibiotic use may lead to withdrawal of the selective pressure.
